Bristol-Myers Squibb (BMY) Approaches New Downside Target of $49.55

Bristol-Myers Squibb (NYSE:BMY) has opened bearishly below the pivot of $50.12 today and has reached the first level of support at $49.78. Analysts will be watching for a cross...